Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of UBX will decline by -100.00% over the next 2 Weeks and hit $0.00 by Monday, August 18, 2025. In that time frame, UBX's share price is expected to range between $0.00 and $0.05.
BearishAverageBullishUBX shares rose +92.77% in Tuesday, July 8, 2025's trading session, rising from a previous close of $0.10 to move at $0.20. The stock demonstrated notable intraday movement (see UBX's key stats for a full breakdown), fluctuating between $0.20 and $0.32, a +59.40% trading range. While recent weeks have seen some volatility, UBX has managed to secure a -33.41% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 299.07K shares changing hands, 248.22K more than the previous session. This amounted to $59.84K in total market activity.
Will UBX Continue Its Downward Trend?
According to analyst ratings and projections for UBX, Unity Biotechnology, Inc. shares are anticipated to decrease by -219.43%, potentially reaching $0.06 per share by August 18, 2025. Short-term technical indicators for UBX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the UBX stock forecast, now is not the best time to buy UBX stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on UBX covering social and institutional perspectives.
UBX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into UBX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 15.65% to 21.92%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 33.56%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 40.03%, maintains a neutral outlook for the long term. Insights into UBX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Unity Biotechnology Short-Term Forecasts
UBX Forecast For Next 5 Days
Our algorithm anticipates Unity Biotechnology (UBX) stock could hit $0.08 by Aug 22, 2025. This represents a -60.62% fall from today's price, following a -70.56% change over the past five days.
UBX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Unity Biotechnology, Inc. (UBX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.07, which would mean a -65.02% decrease from the current price of $0.20. Projections for this period range from a high of $0.25 to a low of $0.00.
UBX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Unity Biotechnology's price over the next three months point to a rise. UBX stock is expected to peak at $1.17 on Feb 02, 2026 before potentially dipping to $0.37 on Mar 20, 2026. On average, UBX is likely to trade around $0.84 in the coming 90 days.
Unity Biotechnology Stock Forecast 2025
Based on our predictive models, Unity Biotechnology (UBX) is expected to trade between $0.40 and $1.58 throughout 2025. This would result in an average price of $0.90, potentially offering investors a +349.78% return from current levels.
Unity Biotechnology, Inc. Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Unity Biotechnology, Inc. (UBX) is positioned to show a strong performance in August 2025. The price is predicted to move between $0.90 and $1.58, settling at an average of $1.21. This could translate to a +504.70% gain.
September 2025
Based on current market signals, Unity Biotechnology, Inc. is projected to trend september 2025. We forecast a trading range from $0.79 to $1.22, with a likely average price of $1.00. Investors could expect a potential return of +399.75%.
October 2025
Our predictive algorithms indicate Unity Biotechnology, Inc. stock may see a shift in October 2025. The expected range spans $0.47–$1.10, with an average target of $0.76. This represents a positive outlook and a possible gain of +279.81%.
November 2025
Analyzing established trends, Unity Biotechnology, Inc. looks set to move in November 2025. Projections place the stock between $0.40 and $1.40, averaging around $0.84. This suggests a +319.79% gain from current levels.
December 2025
Market indicators suggest Unity Biotechnology, Inc. could experience notable changes during December 2025. Prices could fluctuate within $0.55 to $1.23, with a midpoint forecast of $0.85. The stock might deliver a +324.79% gain.
January 2026
Forecasting for January 2026, models estimate that Unity Biotechnology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.48 and $1.15, averaging $0.82. This signals a positive trajectory with potential returns around +309.80%.
February 2026
According to our latest forecast models, Unity Biotechnology, Inc. (UBX) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.58 and $1.17, settling at an average of $0.93. This could translate to a +364.77% gain.
March 2026
Based on current market signals, Unity Biotechnology, Inc. is projected to trend march 2026. We forecast a trading range from $0.21 to $0.99, with a likely average price of $0.69. Investors could expect a potential return of +244.83%.
April 2026
Our predictive algorithms indicate Unity Biotechnology, Inc. stock may see a shift in April 2026. The expected range spans $0.13–$0.76, with an average target of $0.49. This represents a positive outlook and a possible gain of +144.88%.
May 2026
Analyzing established trends, Unity Biotechnology, Inc. looks set to move in May 2026. Projections place the stock between $0.10 and $0.63, averaging around $0.48. This suggests a +139.88% gain from current levels.
June 2026
Market indicators suggest Unity Biotechnology, Inc. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.49, with a midpoint forecast of $0.35. The stock might deliver a +74.91% gain.
July 2026
Forecasting for July 2026, models estimate that Unity Biotechnology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.39, averaging $0.32. This signals a positive trajectory with potential returns around +59.92%.
August 2026
According to our latest forecast models, Unity Biotechnology, Inc. (UBX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.31, settling at an average of $0.31. This could translate to a +54.92% gain.
UBX's history of dividends and stock splits also plays a role in long-term investor confidence.

